Hims & Hers Health, Inc.
corporate_fare Company Profile
Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors HIMS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Hims & Hers Secures $400M Receivables Purchase Facility with JPMorgan
- FDA Panel on Peptide Compounding Set for July 23-24, Critical for Hims' GLP-1 Business
- Hims & Hers Completes Eucalyptus Acquisition, Expands Global Health Platform
- Hims & Hers Completes Eucalyptus Acquisition, Bolstering Consumer Health Platform
- Hims & Hers Director Buys $1.17M in Stock, Signaling Confidence
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for HIMS, detected from its recent SEC filings · latest filing 2026-05-21.
Convertible Notes Issued · Favorable Conversion Terms
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →